DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH.
Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study.
Cephalalgia 2005;
25 (11) 1031-1041
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.